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We have shown that Schistosoma mansoni egg soluble antigen (SEA) prevents diabetes in the nonobese diabetic (NOD) mouse
inducing functional changes in antigen presenting cells (APCs) and expanding T helper (Th) 2 and regulatory T cell (Treg)
responses. A Th2 response to S. mansoni infection or its antigens is key to both the establishment of tolerance and successfully
reproduction in the host. More recently we demonstrated that SEA treatment upregulates bioactive TGFβ on T cells with
consequent expansion of Foxp3+ Tregs, and these cells might be important in SEA-mediated diabetes prevention together with
Th2 cells. In this study we profile further the phenotypic changes that SEA induces on APCs, with particular attention to cytokine
expression and markers of macrophage alternative activation. Our studies suggest that TGFβ from T cells is important not just for
Treg expansion but also for the successful Th2 response to SEA, and therefore, for diabetes prevention in the NOD mouse.
1. Introduction
Helminths employ a range of immunomodulatory strategies
to modulate the host immune response and utilize it to
extend their longevity in the host and facilitate transmission.
Characteristic of infection with helminths such as Schis-
tosoma mansoni is the induction of a Th2 response. Two
products released from eggs have recently been shown to
play important roles in the immune deviation induced by
S. mansoni infection [1, 2]. The NOD mouse provides a
good animal model of the human autoimmune disease, Type
1 diabetes [3]. We have previously shown that S. mansoni
infection or exposure either to the helminth eggs or soluble
extracts of worms (SWA) or eggs (SEA) can prevent diabetes
onset in this mouse [4–6].
As Type 1 diabetes is a Th1-mediated autoimmune
disease [7], any skewing of the response towards Th2 would
result in diabetes prevention. Other responses that have the
potential to impact on diabetes would be the induction of
immunoregulatory cytokines such as IL-10 and TGFβ and
regulatory T cells (Tregs) [8, 9]. We and others have shown
that both SEA and SWA have profound eﬀects on cells of the
innate immune system including dendritic cells (DCs) and
NKT cells [5, 10, 11]. In the case of bone marrow derived
DCs, it has been shown that exposure to S. mansoni antigens
results in DC retention of a more immature phenotype
while inducing them to mediate a Th2 response in vivo
[5, 10]. Immature DCs have been associated with ability to
induce a Th2 response as well as immune tolerance through
induction of Tregs [12]. Although there was little evidence
of phenotypic change in SEA exposed bone marrow derived
murine DCs, recent studies showed increased expression of
mannose receptor (MR), DEC-205, and DC-SIGN as well as
induction of IL-10 [6]. SEA has, furthermore, been shown to
induce Foxp3 expressing Tregs in a TGFβ dependent manner
[6]. Most studies in mice have been carried out using bone
marrow derived APCs and it could be argued that it would
be more relevant to examine the eﬀect of S. mansoni antigens
on isolated splenic DCs as well as in vivo on macrophage
(MΦ) populations. In this manuscript we have addressed in
detail the eﬀect of SEA on functional and phenotypic changes
in DCs and MΦs and the impact that this might have on
the development of diﬀerent T cell subpopulations including
Tregs.
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2. Materials and Methods
2.1. Mice. Female NOD/Tac mice were housed and barrier
bred in the Pathology Department, University of Cambridge
animal facilities (Cambridge, UK) and used between 4–12
weeks of age. All work was conducted under UK Home
Oﬃce project license regulations after approval by the Ethical
Review Committee of the University of Cambridge.
2.2. Preparation of SEA and SWA. Preparation of SEA
and SWA was described previously [13]. Briefly, for SEA,
eggs were harvested from the livers of outbred infected
mice, which were treated to prevent granuloma formation.
Livers were homogenized through sieves and the eggs were
collected, washed, and sonicated in PBS on ice, prior to
centrifugation to separate the saline soluble fraction. SWA
was prepared from adult worms recovered from the portal
venous vasculature. Both antigens were sterile filtered and
endotoxin removed to below <1 EU/mg using Polymixin B
agarose beads (Sigma).
2.3. Cell Culture and Reagents. Cells were cultured in Iscove’s
modified Dulbecco’s medium supplemented with 2 mM L-
glutamine, 100 U/ml penicillin-streptomycin, 50 μM 2-mer-
captoethanol (All Sigma), and 5%–10% fetal calf serum
(FCS) (Gibco). Anti-CD3 (αCD3) (2C11) and αCD28
(37.51) were obtained from BD Pharmingen. LPS from
Salmonella enterica (Sigma) and the TLR1/2 agonist
Pam3CysK4 (Invivogen) were used to stimulate DCs. Anti-
TGFβ (1D11.16) was precipitated from hybridoma super-
natants and dialyzed against PBS before use.
2.4. TGFβ Bioassay. The MLE/PAI cell line is derived from
mink lung epithelial cells and contains firefly luciferase under
PAI-1 promoter control. MLE cells were cultured with 50 μL
of tissue culture supernatants or a double-dilution standard
curve derived from recombinant human TGFβ1 (R&D
Systems) for 18 hours. Cells were then lysed and luciferase
activity was measured using Promega’s Luciferase Reporter
System and a BetaLux scintillation counter (Wallac).
2.5. Flow Cytometry. Cells were stained with appropriate
combinations of the following antibodies:
CD4 (RM4-5)-PCP-Cy5.5, CD25 (PC61)-PE, CD44 (IM7)-
FITC, CD11b (M1/70)-PCP-Cy5.5, CD11c (HL3)-FITC
or APC, galectin-3 (M3/38)-Alexa647, Foxp3 (FJK-16s)-
Alexa647, CD205/DEC-205 (NLDC-145)-FITC, CD206/MR
(MR5D3)-FITC, PD-L1 (M1H5)-PE, CD1d (1B1)-FITC,
SIGN-R1 (22D1)-Alexa647, IL-4 (11B11)-PE, IL-17 (TC11-
18H10)-PE, IL-10 (JES5-16A3)-APC, IL-13 (eBio13A)-
Alexa647, and IFNγ (XMG1.2)-PE-Cy7. Appropriate isotype
control antibodies were from the same manufacturer as
for the specific antibody. Biotinylated polyclonal rat anti-
mouse galectin-1 (R&D Systems) was used in conjunction
with streptavidin-PE (BD Biosciences). Intracellular Foxp3
staining was according to the manufacturer’s instructions
(anti-mouse/rat Foxp3 staining set; eBioscience). For intra-
cellular cytokine staining, cells were stimulated for 5 hours
with 0.5 μg/mL PdBU, and ionomycin and cytokine secretion
was blocked using 1 μg/mL brefeldin A (all Sigma). Cells
were fixed promptly in 1% paraformaldehyde PBS and
permeabilized with 0.5% saponin (Sigma) in staining buﬀer.
For live cell discrimination, 7-aminoactinomycin D (BD
Biosciences) was used. For all staining, Fc receptor ligation
was blocked using anti-FcγR 2.4G2 supernatant grown in
house. Cells were acquired using a BD FACScalibur, a
BD FACScan (BD Biosciences), or a CyAn-ADP (Beckman
Coulter) and analyzed using FlowJo (TreeStar) software.
2.6. Cell Purification. Naı¨ve T cells (>98% pure) were
sorted from splenic cell suspensions on the basis of
CD4+CD44lowCD25− using a MoFlo (Beckman Coulter).
Splenic dendritic cells (>90% pure) were purified by
immunomagnetic selection on an autoMACS Pro (Miltenyi
Biotec). Briefly, spleens were digested using Liberase CI
(Roche) and passed through a 70 μm strainer to obtain
a single-cell suspension. Nonspecific binding was blocked
using 2.4G2 anti-FcγR supernatant, and DCs were posi-
tively selected using pan-DC microbeads (Miltenyi Biotec).
For T cell polarization, immature DCs were diﬀerentiated
from bone marrow precursors using GM-CSF as previ-
ously described [5]. Peritoneal exudates cells, PECs (∼50%
CD11bhi MΦs), were flushed from the peritoneal cavity
by lavage with cold PBS. Pancreatic and hepatic leukocytes
populations were isolated from collagenase digested samples
by centrifugation through a 33% Percoll (GE Healthcare)
gradient as previously described (EJI).
2.7. RNA Isolation and Real-Time RT-PCR. Total RNA was
extracted using an RNeasy Mini kit, converted to cDNA
using a Reverse Transcription kit, and quantified in real
time using SYBR green fast PCR (all Qiagen). cDNA was
analyzed in duplicate reactions with amplification of target
gene and housekeeping gene (hypoxanthine phosphoribosyl
transferase 1, Hprt1) transcripts performed on the same
reaction plate on a 7500 fast real-time PCR system (Applied
Biosystems). Proprietary QuantiTect Primer Assays for all
genes were purchased from Qiagen. Data are presented after
normalization to the threshold cycle (CT) for Hprt1, either as
CTGene1−CTHprt1 or as Hprt−RE = 1000× 2(CTGene1−CTHprt1).
2.8. Statistics. Statistical analyses were performed using
GraphPad Prism 4 software. Tests performed and calculated
two-tailed P values are indicated in the individual figure
legends. For nonparametric datasets, the Mann Whitney
unpaired t test was employed.
3. Results
3.1. SEA Induces Functional and Phenotypic Changes on
Dendritic Cells, Creating the Ideal Conditions for Th2 and Treg
Cell Expansion. SEA triggers important changes in dendritic
cell (DC) function, which are key in initiating modulation
of the host immune system [14–19]. In the absence of
additional TLR stimuli, we have shown that small consistent
phenotypic changes occur when DCs are stimulated in vitro
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Figure 1: Schistosome soluble antigens change the phenotype of primary splenic DCs. (a) DCs, isolated by immunomagnetic selection,
increase surface expression of CLRs in response to SEA stimulation. DCs were cultured overnight with 25 μg/ml SEA and were analyzed by
flow cytometry, excluding nonviable (7-AAD+) cells. Data are representative of at least three independent experiments. (b) SEA enhances
bioactive TGFβ production by DCs stimulated with Pam3CysK4. DCs were isolated by immunomagnetic selection and cultured for 48
hours at 1× 105/well with 100 ng/ml LPS, 100 ng/ml Pam3CysK4, and/or 25 μg/ml SEA. The supernatants were then cultured with a TGFβ-
responsive cell line and compared to a dose-response curve for recombinant human TGFβ1. Data shown are the means +/−SEM of triplicate
wells. (c) SEA decreases LPS-induced IL-12p35 and p40 mRNA levels in splenic DCs. Cells (5 × 105) were stimulated for 4 hours in the
presence of 100 ng/ml LPS and/or 25 μg/ml SEA, and mRNA was analyzed in real time using qPCR. Data shown are the means +/−SEM of
data from three experiments. ∗P < .05 by paired t test, two tailed.
with SEA [6]. This is particularly seen with C-type lectin
receptors (CLRs). These receptors such as DEC-205, SIGN-
R1, MR, and galectins 1 and 3, expressed on the surface
of APCs, have been shown to recognize glycans present
in schistosome antigens and are important for adaptive
responses induced by the parasite [20–25]. Here we confirm
that primary splenic DCs stimulated in vitro with SEA
also upregulate the surface expression of galectins 1 and 3,
and SIGN-R1, thus possibly increasing their ability to bind
schistosome self-glycans (Figure 1(a)). Using bone marrow
generated DCs, we have shown that the IL-10/IL-12 axis
can be tilted by SEA [5, 6]. In Figures 1(b) and 1(c) we
show that purified spleen CD11c+ DCs stimulated in vitro
with SEA in the presence of TLR ligands upregulate the
secretion of bioactive TGFβ whereas IL-12 (p40 and p35)
mRNA expression is downmodulated.
Interestingly, SEA in association of Pam3CysK4 (a
TLR1/2 ligand) induces the secretion of bioactive TGFβ, but
this eﬀect is not seen in combination with LPS (TLR4) or
FSL-1 (TLR2/6, Figure 1(b)). No significant changes were
found in IL-10 mRNA expression from purified splenic DCs
(Figure 1(c)).
3.2. SEA Alternatively Activates MΦs, which May Favor Treg
and Th2 Cell Expansion In Vivo. We examined the eﬀect
of i.p. injected SEA on cellular phenotypes and function in
the peritoneal cavity of NOD female mice. Examination of
cytokine expression at the RNA level revealed that, while
IL-4 mRNA was not detected in the control peritoneal cells
(PECs), there was a substantial expression in PECs from
SEA-treated mice, together with increased expression of IL-2,
IL-6, IL-10, and TGFβ (Figure 2(a)). Interestingly, IL-12p35
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Figure 2: Schistosome antigens alternatively activate MΦs in vivo. (a) Increased expression of anti-inflammatory cytokines and mediators in
the peritoneal cavity following SEA treatment of NOD mice are illustrated. (b) Induction of arginase and Fizz-1, markers of MΦ alternative
activation in PECs is given. (c) Alternative activation in response to S. mansoni antigens shows a distinct pattern from that of the classical
activation seen in response to LPS. Six-week-old female NOD mice were injected i.p. with 50 μg SEA or 10 μg LPS on day 0 and day 7, and
PECs were collected for FACS and RT-qPCR analysis on day 10. Data shown are the responses of six mice per group for (a) and (b) or one
mouse per condition for (c). Statistical analysis by Mann Whitney U test, two-tailed.
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Figure 3: Schistosome antigens alternatively activate MΦs in vivo. CD11b+ peritoneal MΦs upregulate surface expression of (a) mannose
receptor, (b) galectin-3, (c) PD-L1, and (d) CD1d, with accompanying increases in mRNA levels in whole PECs. Data from six mice per
group treated and analyzed as in Figure 2 are shown. Statistical analysis by Mann Whitney U test, two-tailed.
expression was not aﬀected by SEA while IL-12p40 was
upregulated (Figure 2(a)). Expression of other subunits of
the IL-12 family (EBI3, p28 for IL-27 and p19 for IL-23)
was not aﬀected by SEA treatment (data not shown). The
significant upregulation of TGFβ suggests the presence of
alternatively activated macrophages (aaMΦs) in PECs from
SEA-treated mice and the increased expression of integrin
β8 (Figure 2(a)) indicates an increased capacity to activate
TGFβ at the point of the immunological synapse [26].
Further support for the presence of aaMΦs is the upregulated
expression of arginase-1 and 2 as well as Fizz-1 (Figure 2(b)).
By comparison, treatment of NOD mice with LPS increased
iNOS expression but, unlike with SEA, the full range of
markers of alternative activation was not seen (Figure 2(c)).
Analysis of surface marker expression on PECs identified
potentially relevant costimulatory molecules that might
indicate the presence of aaMΦs as well as CLRs involved
in the binding of SEA. After SEA injection there is an
increased percentage of cells expressing MR on peritoneal
MΦs (pMΦs) with no significant change in mean fluores-
cent intensity (MFI) (Figure 3(a)). This increased surface
expression was mirrored by an augmented receptor mRNA
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expression in whole PECs. The expression of SIGN-R1 and
Dectin-1 was not altered by SEA when measured by FACS or
by RT-PCR (data not shown).
Galectin-3 expression has been shown to be a feature
of aaMΦs and its upregulation is IL-4 dependent [27].
Following SEA injection we find an increased percentage
of galectin-3-expressing pMΦs and upregulation of both
galectin 1 and 3 mRNA (Figure 3(b)). SEA increased PD-
L1 expression on pMΦs, with an accompanying increase in
message for PD-L1 and 2 in whole PECs (Figure 3(c)). At
this time point SEA also increased the expression of MHC
class II (data not shown) and the nonclassical class I molecule
CD1d (Figure 3(d)). The negative costimulatory molecule
programmed death ligand 1 (PD-L1) has been shown to be
upregulated on aaMΦs [28].
Altogether our findings indicate that SEA alternatively
activates MΦs in the peritoneal cavity and suggests that this
anti-inflammatory signature might be tied to expansion of
Tregs and Th2 cells.
3.3. SEA Induces IL-4, IL-10, and IFN-γ/IL-10 Double Pro-
ducing T Cells In Vivo. Schistosome antigens are powerful
inducers of Th2 responses, and this has been extensively
explored using splenic and peripheral lymph node cells
[29, 30]. In this study, we have extended our analysis to
the pancreas in order to assess the potential impact of
exposure to helminth antigens on diabetes and on the
liver, the major site of immunopathology in schistosome
infection. Kupﬀer cells, specialized liver MΦs, have also
been shown to initiate Th2 responses to egg antigens,
and we have previously observed changes in classical NKT
cell populations in the liver following schistosome antigen
treatment of NOD mice [5]. After a short course of treatment
with SEA, the intracellular cytokine expression in CD4+ T
cells is profoundly changed in the spleen, pancreas, and
liver of prediabetic NOD mice (Figures 4(a), 4(b), and
4(c)). The systemic Th2/Treg response induced by SEA is
accompanied by the signature of MΦ alternative activation
in the pancreatic infiltrate of prediabetic NOD mice and is
presumably beneficial for diabetes prevention (Figures 4(b)
and 4(d)).
Together with the expected Th2 [5] and IL-10 Tr1 (CD4+
IL-10+) response, we have identified a population of CD4+
T cells expressing both IL-10 and IFNγ in response to SEA
(Figures 4(b) and 4(c)). As IL-10-producing Th1 cells have
been proposed as a self-regulating class of Th1 cells, the
presence of this CD4+ T cell population in the pancreas
might also mitigate Th1 driven diabetes pathology.
3.4. TGFβ Is Also Important for SEA Th2-Induced Response
In Vivo and In Vitro. We have previously demonstrated that
TGFβ is important for the generation and expansion of
Foxp3+ Tregs in NOD mice [6]. Our preliminary experi-
ments suggest that the Th2 response induced by SEA can also
be regulated by TGFβ. Figure 5(a) shows that the increased
percentage of IL-4/IL-13 double-producing CD4+ T cells
that we observe in SEA-treated NOD mice can be decreased
by in vivo coadministration of SEA together with a TGFβ
neutralizing antibody. This eﬀect is particularly evident in
the pancreas and not the spleen or PLN (Figure 5(a) and data
not shown).
We have also confirmed our findings with an in vitro
polarization assay. Using bone marrow generated DCs and
naı¨ve T cells from NOD mice, we have previously shown
that SEA increases Foxp3+ Tregs in vitro and that TGFβ
neutralization reverts this eﬀect [6]. Figure 5(b) shows that
blocking TGFβ in vitro reduces the generation of IL-10 and
IL-4 single- and double-producing CD4+ T cells. Also in
vitro we observe that SEA can induce the generation of
IL-10/IFNγ double-expressing CD4+ T cells and that TGFβ
regulates this population. These preliminary data suggest
that the role of TGFβ in adaptive responses to schistosome
antigens is quite complex and is not restricted to the
generation/expansion of Foxp3+ Tregs.
3.5. Egg But Not Worm S. mansoni Soluble Antigens Induce
Foxp3+ Tregs In Vivo and In Vitro. We have recently sug-
gested that Foxp3+ Tregs have an important role to play in
SEA immunomodulation and prevention of autoimmunity
in the NOD mouse [6]. We found that in vitro only SEA,
and not SWA, was able to induce Foxp3 in naı¨ve T cells from
NOD mice. To examine the eﬀects of these helminth antigens
on Tregs in vivo, we injected SEA and SWA into NOD mice.
Figure 6(a) shows that following a short in vivo treatment
with S. mansoni antigens Foxp3+ Tregs increase only in SEA,
but not SWA-treated mice. Further analysis of the liver of
SEA-treated NOD mice revealed a highly significant increase
in Foxp3+ Tregs, which is consistent with the fact that Tregs
are found in the egg-induced granulomas in the liver and
regulate their formation (Figure 6(b)) [31, 32].
These in vivo studies, therefore, support our in vitro
studies and emphasize diﬀerences between the modes of
activity of SEA and SWA.
4. Discussion
There has been considerable interest in defining the ways in
which S. mansoni infection perturbs the immune system and
induces a Th2 response. As we have previously shown that
S. mansoni antigens are able to inhibit the Th1-mediated
autoimmune disease Type 1 diabetes, we were particularly
interested in clarifying this in NOD mice.
We focused our attention on DCs and MΦs as these
cell types play a role in orchestrating the adaptive immune
response. Much work has been carried out examining the
eﬀects of SEA on in vitro generated DCs, and while this has
produced valuable insights, we felt that it is important to
analyze the eﬀects on populations of cells which would be
exposed to S. mansoni antigens in vivo.
In our studies of splenic DCs we showed that following
exposure to SEA in vitro these cells upregulated galectins
1 and 3, SIGN-R1, and DEC-205 following exposure to
SEA in vitro. This is interesting because these C-type lectin
receptors (CLRs) have been shown to recognize glycans
present in schistosome antigens and are important for
adaptive responses induced by the parasite. Galectins are
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Figure 4: The systemic Th2 response to SEA is accompanied by local induction of IL-10 in the pancreas and liver. Increased proportions of
CD4+ T cells expressing IL-4 were seen in the spleen (a), the pancreas (b), and the liver (c). In the pancreas and liver, SEA treatment triggered
IL-10 production from Th1 cells. (d) Increased mRNA for Th2 and regulatory cytokines in the pancreas of mice treated with schistosome
antigens are shown. Six-week-old female NOD mice were injected i.p. with 50 μg SEA on day 0 and day 7, and lymphocytes from spleen,
pancreas, and liver were collected for FACS and RT-qPCR analysis on day 10. Data shown are the responses of 5-6 mice per group for (a)–(c)
or a pool of three mice per condition for (d). Statistical analysis by Mann Whitney U test, two-tailed.
of particular interest as they have the potential to alter
sensitivity to cytokines and apoptosis [20, 33]. Exposure to
SEA upregulates, therefore, the capacity of the DC to respond
to further exposure to helminth glycans.
Some diﬀerences were observed in the response of DCs
and MΦs to SEA. This was seen in the eﬀects of SEA on
IL-12. In vitro, we found that splenic DCs downmodulated
IL-12p35 and p40 in response to SEA whereas the in vivo
response of pMΦs showed an upregulation of the IL-12p40
response with no eﬀect on IL-12p35 (Figure 2(a)). This
presents another interesting way in which the Th1 response
could be modulated as it has been suggested that excess
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Figure 5: TGFβ modulates the Th2 response to SEA in vitro and in vivo. (a) Treatment of NOD mice with anti-TGFβ reduces the Th2
response to SEA in vivo. Female NOD mice (10-11 weeks of age) were injected i.p. with 50 μg SEA on days 0 and 5, 5 mg anti-TGFβ on days
0, 2, and 5, and cells were taken for analysis on day 10. Data shown are from a single experiment using anti-TGFβ and SEA. (b) Antibody
neutralization of TGFβ in vitro diminishes the Th2 response to SEA. Naı¨ve CD4+ T cells (5 × 105) were cultured for five days with bmDCs
(105) and 0.5 μg/ml αCD3 in the presence of SEA (10 μg/ml) and/or anti-TGFβ (20 μg/ml). FACS plots from one of three independent
polarization experiments are shown.
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IL-12p40 in both a monomeric (p40) and dimeric (p80)
forms might antagonize the IL-12 receptor [34], providing
a feedback mechanism to downmodulate Th1 responses.
With regard to eﬀects of SEA administration in vivo
on APC phenotype and function, several were noted that
again had the potential to modify a diabetogenic Th1
response. SEA increased PD-L1 expression on pMΦs, with an
accompanying increase in message for PD-L1 and 2 in whole
PECs (Figure 3(c)). The negative costimulatory molecule
programmed death ligand 1 (PD-L1) has been shown to
be upregulated on aaMΦs [28], as well as playing a role
in diabetes regulation in NOD mice [35]. Eﬀects of i.p.
injected SEA were noted in several sites, some of which were
particularly relevant to diabetes regulation. After a short
course treatment of NOD mice with SEA, the intracellular
cytokine expression in CD4+ T cells was profoundly changed
in the spleen, pancreas, and liver of prediabetic NOD
mice (Figures 4(a), 4(b), and 4(c)). The systemic Th2/Treg
response induced by SEA was accompanied by the signature
of MΦ alternative activation in the pancreatic infiltrate of
prediabetic NOD mice and would be beneficial for diabetes
prevention (Figures 4(b) and 4(d)). Together with the
expected Th2 [5] and IL-10 Tr1 (CD4+ IL-10+) response,
we have identified a population of CD4+ T cells expressing
both IL-10 and IFNγ in response to SEA (Figures 4(b) and
4(c)). IL-10/IFNγ double-producing CD4+ T cells were first
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identified in murine model of Leishmania infection and
shown to mediate chronic pathology in the skin lesions
with delayed/reduced clearance of infection [36, 37]. IL-10-
producing Th1 cells have been proposed as a self-regulating
class of Th1 cells, and therefore, this CD4+ T cell population
in the pancreas might also mitigate Th1 driven diabetes
pathology.
We have previously demonstrated that SEA has direct
eﬀects on DCs and T cells and suggest that the simultaneous
interaction with both cell types is important for determining
the host immune response. These in vitro studies had
highlighted a role for TGFβ in the SEA-mediated induction
of regulatory T cells; here we provide data suggesting that
this immunomodulatory cytokine may also play a role in
modulating the Th2 response in vivo as well as in vitro.
5. Conclusion
S. mansoni and its soluble antigens can prevent autoimmune
diabetes in NOD mice. This paper summarizes and confirms
our previous work demonstrating that SEA modulates the
immune response through alteration of CLR expression,
cytokine production, and Treg expansion in NOD mice. In
particular we show how functional and phenotypic changes
on DCs and MΦs, the expansion of diﬀerent T helper
cell subsets (Th2), and Treg cell types (IL-10/IFN-γ double
producers and Foxp3+ Tregs) might contribute to diabetes
prevention in NOD mice (Figure 7).
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